WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

WMT

114.55

+1.25%↑

COST

925.26

+1.08%↑

TGT

105.58

-0.61%↓

59.51

-0.45%↓

DG.US

142.85

-0.76%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

19.79 -0.75

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.76

Max

19.97

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	21.122 28.085
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+94.9% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-24

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-34M 348M
Ankstesnė atidarymo kaina	20.54
Ankstesnė uždarymo kaina	19.79

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-10 00:16; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Drops Merger With JenaValve

2026-01-11 23:46; UTC

Rinkos pokalbiai

Gold Rises Amid Geopolitical Risks -- Market Talk

2026-01-11 23:35; UTC

Rinkos pokalbiai

Oil Rises Amid Middle East Tensions -- Market Talk

2026-01-11 23:25; UTC

Uždarbis

Stock Futures Drift Lower With Bank Earnings, CPI on Tap -- Barrons.com

2026-01-11 22:05; UTC

Rinkos pokalbiai

Iron Ore Outlook Weighed by Soft China Steel Markets, Rising Supply -- Market Talk

2026-01-10 12:00; UTC

Įsigijimai, susijungimai, perėmimai

Copper Is the Prize in Mining Megadeals -- WSJ

2026-01-10 09:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-01-10 09:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Basic Materials Roundup: Market Talk

2026-01-10 09:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-01-09 22:18; UTC

Rinkos pokalbiai

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

2026-01-09 21:50; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2026-01-09 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Basic Materials Roundup: Market Talk

2026-01-09 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-01-09 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-01-09 21:43; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

2026-01-09 20:39; UTC

Rinkos pokalbiai

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

2026-01-09 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

2026-01-09 20:36; UTC

Įsigijimai, susijungimai, perėmimai

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

2026-01-09 20:30; UTC

Rinkos pokalbiai

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

2026-01-09 20:15; UTC

Rinkos pokalbiai

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

2026-01-09 20:07; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-09 20:07; UTC

Rinkos pokalbiai

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

2026-01-09 19:58; UTC

Įsigijimai, susijungimai, perėmimai

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

2026-01-09 19:42; UTC

Rinkos pokalbiai

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

2026-01-09 19:38; UTC

Įsigijimai, susijungimai, perėmimai

Wolters Kluwer Acquires StandardFusion >WTKWY

2026-01-09 19:31; UTC

Uždarbis

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

2026-01-09 19:28; UTC

Uždarbis

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

2026-01-09 18:30; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

2026-01-09 18:23; UTC

Rinkos pokalbiai

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

2026-01-09 17:20; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

94.9% į viršų

12 mėnesių prognozė

Vidutinis 39 USD 94.9%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.